Clinical trialNCT04962880CompletedObservational

HRR Prevalence in LatAm PROSPECT Study

SponsorAstraZenecaEnrollment388Castration-resistant Prostate Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Determine the prevalence of homologous recombination repair (HRR) gene mutations in participants with mCRPC in Latin America (LatAm) between February 2021 and January 2022.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Alejandro Crismatt, MD
Centro Hemato Oncológico Panamá (CHOP)
Principal Investigator
clinicaltrials.gov ↗
Arturo Delgado Herrera, MD
Centro Médico Nacional Siglo XXI (CMNSXXI)
Principal Investigator
clinicaltrials.gov ↗
Gabriel Garbaos, MD
Fundación Estudios Clinicos
Principal Investigator
clinicaltrials.gov ↗
Jorge A Chaves Porras, MD
Instituto de Investigaciones en Ciencias Médicas (ICIMED)
Principal Investigator
clinicaltrials.gov ↗
Martin Angel, MD
INSTITUTO ALEXANDER FLEMING
Principal Investigator
clinicaltrials.gov ↗
Miguel A Álvarez Avitia, MD
Instituto Nacional de Cancerología (INCAN)
Principal Investigator
clinicaltrials.gov ↗
Pedro H Isaacsson Velho, MD
Centro de Pesquisa Hospital Moinhos de Vento
Principal Investigator
clinicaltrials.gov ↗
Ray Manneh Kopp, MD
Sociedad de Oncología y Hematología del Cesar S.A.S.
Principal Investigator
clinicaltrials.gov ↗
Silvia Neciosup, MD
Centro de Investigación Oncosalud - RCI N° 166
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
Buenos Aires, Argentina
Research Site
Rosario, Argentina

Brazil

Research Site
Porto Alegre, Brazil
Research Site
Rio de Janeiro, Brazil
Research Site
São Paulo, Brazil

Colombia

Research Site
Bogotá, Colombia

Costa Rica

Research Site
San José, Costa Rica

Mexico

Research Site
Mexico City, Mexico DF, Mexico
Research Site
Mexico City, Mexico

Panama

Research Site
Panama City, Panama

Peru

Research Site
Lima, Peru

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 21 Apr 2021
Primary completion: 8 Apr 2022
Completion: 8 Apr 2022
Last update posted: 14 Apr 2023
Registered enrollment: 388
Registry id: NCT04962880

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.